 |
|
safingol
A saturated derivative of sphingosine. As an inhibitor of protein kinase C (PKC), safingol competitively binds to the regulatory phorbol-binding domain of PKC, a kinase involved in tumorigenesis. This agent has been shown to act synergistically with other chemotherapeutic agents and may potentiate chemotherapy drug-induced apoptosis in vitro and in vivo. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonym: | | sphinganine | | | | US brand name: | | Kynacyte | | | | Chemical structure names: | | - 2-amino-1,3-dihydroxyoctadecane
- L-threo-dihydrosphingosine
| | |
|
|
